A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
Clinical trial NCT00463242 · COMPLETED
Trial details
- NCT number
- NCT00463242
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-06-01
- Enrollment
- 501
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.